Details for Patent: 10,350,170
✉ Email this page to a colleague
Which drugs does patent 10,350,170 protect, and when does it expire?
Patent 10,350,170 protects ORGOVYX and is included in one NDA.
This patent has twenty-six patent family members in twenty-three countries.
Summary for Patent: 10,350,170
Title: | Solid preparation |
Abstract: | Provided is a solid preparation showing improved stability of N-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy-3-pyr- idazinyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-- N'-methoxyurea and a salt thereof in the solid preparation, and a method of stabilizing the compound in a solid preparation. A tablet containing not less than 25 mass % of the compound; a solid preparation containing (1) the compound, and (2) a fat and oil-like substance having a low melting point, which is selected from polyethylene glycol, glycerol monostearate and triethyl citrate; a method of stabilizing the compound in a tablet, including adding not less than 25 mass % of the compound; and a method of stabilizing the compound, including adding a fat and oil-like substance having a low melting point, which is selected from polyethylene glycol, glycerol monostearate and triethyl citrate to a solid preparation containing the compound. |
Inventor(s): | Yamane; Ikuro (Osaka, JP), Nomura; Yukihiro (Osaka, JP), Nishimoto; Yutaka (Osaka, JP), Hoshina; Wataru (Osaka, JP) |
Assignee: | Takeda Pharmaceutical Company Limited (Osaka, JP) |
Application Number: | 15/553,852 |
Patent Claim Types: see list of patent claims | Use; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 10,350,170
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sumitomo Pharma | ORGOVYX | relugolix | TABLET;ORAL | 214621-001 | Dec 18, 2020 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 10,350,170
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Japan | 2015-037462 | Feb 26, 2015 |
PCT Information | |||
PCT Filed | February 25, 2016 | PCT Application Number: | PCT/JP2016/055540 |
PCT Publication Date: | September 01, 2016 | PCT Publication Number: | WO2016/136849 |
International Family Members for US Patent 10,350,170
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2016224503 | ⤷ Try a Trial | |||
Brazil | 112017018173 | ⤷ Try a Trial | |||
Canada | 2978223 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |